EU MedTech Stocks Upgraded by Analysts

By EC Assets · Published 23 June 2026

Analyst reports indicate a recent upgrade for European MedTech stocks. This comes amid signs of growth inflection and attractive valuations within the sector. The consensus fair value estimate for Sanara MedTech has risen. It moved from US$34.00 to approximately US$34.33 per share. This provides investors with a refreshed reference point. Johnson & Johnson MedTech is recruiting for a Senior Analyst, Order to Cash Reliability & Governance. This role may consider remote work options. Getinge is a leading medtech company. It assists customers in healthcare and life science sectors with reliable care and cure. Clarivate provides Medtech-expert driven data and insights. These resources aim to empower Medtech innovation and help medical device and diagnostic companies. Several analyst roles within the MedTech space focus on financial and operational aspects. A Value Creation Analyst at Johnson & Johnson in Bogotá supports commercial value creation. This involves partnering with selling and commercial teams to deliver pricing, analytics, and market insights. An Analyst, I2C (Invoice-to-Cash) supports order-to-cash activities. This ensures accurate billing, timely collections, and effective dispute resolution. A Financial Analyst at Coloplast A/S is responsible for reporting actuals, forecasting, and variance analysis. A Senior Analyst in Order to Cash Reliability & Governance tests processes and performs root cause analysis for issues impacting Medical Technology. Another Senior Financial Analyst for Global Finance focuses on expertise in Innovative Medicine and MedTech. A Surgery MedTech Marketing Analyst supports marketing initiatives for the Surgery South MedTech business. This role emphasizes operational excellence and insights. This article is intended for informational purposes only. It does not constitute investment advice.